new injectable biologic for moderate to severe plaque psoriasis called Stelara (stel-AR-a)
November 2009
You'll soon hear about a new injectable biologic for moderate to severe plaque psoriasis called Stelara (stel-AR-a).
It's the first of a new class. It inhibits the inflammatory proteins interleukin-12 and -23...instead of tumor necrosis factor.
Some evidence suggests that Stelara might be more effective than Enbrel for psoriasis. But this isn't proven yet...and there are concerns about long-term safety.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote